KS Industry
Key metrics
Earnings
| Revenue, Q3 2026 | ₩11.3bn |
|---|---|
| Revenue QoQ | +19.1% |
| Revenue YoY | -6.4% |
| Operating income, Q3 2026 | ₩345m |
| Operating income QoQ | Turned to profit |
| Operating income YoY | Turned to profit |
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩0 |
| Treasury shares cancelled (number), last 3 months | 0 shares |
| Treasury shares cancelled, last 3 months, % of shares | 0.0% |
| Buyback decided, last 12 months | ₩0 |
| Buyback decided, last 12 months, % of shares | 0.0% |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩0 |
| Treasury shares cancelled (number), last 12 months | 0 shares |
| Treasury shares cancelled, last 12 months, % of shares | 0.0% |
Potential dilution
| CB/BW/EB issued, last 12 months | ₩7.0bn |
|---|---|
| Rights offering new shares, last 12 months | 12,173,826 shares |
| Potential new shares, last 12 months | 16,486,826 shares |
| Potential new shares, % of shares | 166.4% |
| Conversion price adjustments, last 12 months | 0 |
Supply contracts
| Supply contracts, last 12 months | ₩0 |
|---|---|
| Supply contracts vs prior-year revenue | 0.0% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Disclosure activity
| DART filings, last 3 months | 44 |
|---|---|
| DART filings, previous 3 months | 27 |
Insider transactions
| Open-market buys, last 12 months (shares) | 0 shares |
|---|---|
| Open-market buys, last 12 months (amount) | ₩0 |
| Open-market sells, last 12 months (shares) | 0 shares |
| Open-market sells, last 12 months (amount) | ₩0 |
| Net open-market buying, last 12 months (shares) | 0 shares |
| Insiders who bought, last 12 months | 0 |
Insider transactions (last 12 months)
Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.
| Trade date | Insider (role) | Type | Shares | Price | Amount | |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | e-medicine.Co.Ltd. (10%+ shareholder) | Other (Paid-in new shares) | +3,117,692 shares | — | — | |
| Oct 2, 2026 | e-medicine.Co.Ltd. (10%+ shareholder) | Other (Paid-in new shares) | +4,885,993 shares | — | — | Reported late |
| Aug 14, 2026 | Marinrobotikseuje1hotujajohap (10%+ shareholder) | Other | -904,977 shares | ₩4,420 | ₩4.0bn | |
| Aug 14, 2026 | Marinrobotikseuje1hotujajohap (10%+ shareholder) | Other | -678,733 shares | ₩4,420 | ₩3.0bn | |
| Aug 14, 2026 | Marinrobotikseuje1hotujajohap (10%+ shareholder) | Other | -702,357 shares | ₩4,420 | ₩3.1bn | |
| Mar 24, 2026 | Marinrobotikseuje1hotujajohap (10%+ shareholder) | Other (Convertible bond acquisition) | +9,140,271 shares | — | — | |
| Mar 24, 2026 | Marinrobotikseuje1hotujajohap (10%+ shareholder) | Other (Capital reduction) | -6,854,204 shares | ₩4,420 | ₩30.3bn | Reported late |
| Jan 28, 2026 | Keieseuai1hoseongjangtujajohap (10%+ shareholder) | Other (Third-party placement) | +6,195,146 shares | ₩1,292 | ₩8.0bn |
Annual financials
| Year | Revenue | Operating income |
|---|---|---|
| 2025 | ₩39.4bn | -₩4.6bn |
| 2024 | ₩24.7bn | -₩749m |
| 2023 | ₩86.4bn | ₩10.9bn |
Filing timeline
-
KS Industry third-party allotment of 4,170,141 new shares for ₩5.0bn
KS Industry filed a rights offering of 4,170,141 new shares, equal to 27.8% of existing shares (by our calculation), to raise ₩5.0bn through third-party allotment. The main purpose of the funds is debt repayment. The issue amount equals 12.7% of FY2025 revenue (by our calculation).
-
KS Industry rights offering of 3,117,692 new shares for ₩4.0bn
KS Industry filed a rights offering of 3,117,692 new shares, equal to 20.8% of existing shares by our calculation, to raise ₩4.0bn. The funds are for debt repayment and the allocation method is third-party allotment. The issue amount equals 10.1% of FY2025 revenue by our calculation.